GLP 1
Mazdutide Who Should (and Shouldn’t) Take It: Eligibility & Contraindications
Mazdutide is approved in China for adults with a BMI of 28 or higher, or BMI of 24 or higher with at least one weight-related comorbidity.
Mazdutide Latest Research: New Indications, Trials & What’s Coming
Mazdutide has the most active research pipeline of any drug in the GLP-1/glucagon dual agonist class.
Mazdutide Drug Interactions: What You Can and Can’t Take with It
Mazdutide doesn’t have a long list of dangerous drug interactions, but a few categories matter.
Mazdutide Dosing Guide: Schedule, Titration & What to Expect Each Week
Mazdutide uses a four-step titration over 12 to 16 weeks before patients reach a maintenance dose.
Managing Nausea on GLP-1: Diet Tricks That Actually Help
Nausea is the most common side effect on GLP-1 medications, full stop. In the STEP 1 trial (Wilding et al.
Mazdutide Cost Breakdown: Brand, Compounded, Insurance & Savings Options
Mazdutide pricing exists only in China today, where Innovent launched it under the brand name Xinerjia in mid-2025.
Maintenance After GLP-1: Building Habits That Last
The hard truth about weight maintenance after GLP-1 medications: most people don’t maintain. STEP 4 (Rubino et al.
Low Dose vs High Dose GLP-1: Finding Your Sweet Spot
GLP-1 trial protocols escalate everyone to maximum dose. STEP 1 pushed all patients to semaglutide 2.4 mg. SURMOUNT-1 pushed to tirzepatide 15 mg.
Liraglutide Switching to or From: Transition Protocols & Dose Conversion
Most patients on liraglutide eventually consider switching. The reasons vary. Daily injections get tiring compared with weekly options.
